Cargando…

Overcoming the challenge of long-term storage of mRNA-lipid nanoparticle vaccines

Detalles Bibliográficos
Autores principales:	Young, Rachel E., Hofbauer, Samuel I., Riley, Rachel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023316/ https://www.ncbi.nlm.nih.gov/pubmed/35452599 http://dx.doi.org/10.1016/j.ymthe.2022.04.004

Ejemplares similares

Long-term storage of lipid-like nanoparticles for mRNA delivery
por: Zhao, Pengxuan, et al.
Publicado: (2020)

From lipids to lipid nanoparticles to mRNA vaccines
por: Horejs, Christine
Publicado: (2021)

Ionizable lipid nanoparticles for in utero mRNA delivery
por: Riley, Rachel S., et al.
Publicado: (2021)

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
por: Muramatsu, Hiromi, et al.
Publicado: (2022)

Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
por: Uddin, Mohammad N., et al.
Publicado: (2021)

mRNA vaccines: A matter of delivery
por: Cao, Yuhong, et al.
Publicado: (2021)

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
por: Hassett, Kimberly J., et al.
Publicado: (2019)

Future considerations for the mRNA-lipid nanoparticle vaccine platform
por: Igyártó, Botond Z, et al.
Publicado: (2021)

Principles for designing an optimal mRNA lipid nanoparticle vaccine
por: Kon, Edo, et al.
Publicado: (2022)

Lipid nanoparticles in the development of mRNA vaccines for COVID-19
por: Wilson, Barnabas, et al.
Publicado: (2022)

Elucidation of lipid nanoparticle surface structure in mRNA vaccines
por: Wang, Mingzhang Maple, et al.
Publicado: (2023)

A Tolerizing mRNA Vaccine against Autoimmunity?
por: Furlan, Roberto
Publicado: (2021)

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2
por: Ai, Liangxia, et al.
Publicado: (2023)

Debunking mRNA Vaccine Misconceptions—An Overview for Medical Professionals
por: Hitti, Frederick L., et al.
Publicado: (2021)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

Uveitis following mRNA COVID-19 vaccination: Is it real?
por: Murugan, Sivaraman Bala, et al.
Publicado: (2023)

Lipid nanoparticles for mRNA delivery
por: Hou, Xucheng, et al.
Publicado: (2021)

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
por: Schoenmaker, Linde, et al.
Publicado: (2021)

Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
por: Wang, Wei, et al.
Publicado: (2022)

Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
por: Swetha, K., et al.
Publicado: (2023)

Formulation of Lipid-Free Polymeric Mesoscale Nanoparticles Encapsulating mRNA
por: Skelton, Rachel, et al.
Publicado: (2022)

Safety of Enteral Nutrition Practices: Overcoming the Contamination Challenges
por: Sinha, Saswati, et al.
Publicado: (2020)

COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
por: Sultana, Janet, et al.
Publicado: (2022)

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
por: Crombie, Jennifer L., et al.
Publicado: (2021)

Endless Challenges in Overcoming Complications Associated with Endoscopic Submucosal Dissection
por: Ono, Satoshi, et al.
Publicado: (2019)

Taylor Dispersion Analysis to support lipid-nanoparticle formulations for mRNA vaccines
por: Malburet, Camille, et al.
Publicado: (2022)

Design Strategies for and Stability of mRNA–Lipid Nanoparticle COVID-19 Vaccines
por: Liu, Ting, et al.
Publicado: (2022)

Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
por: Hajiaghapour Asr, Mena, et al.
Publicado: (2023)

A review of technological developments in lipid nanoparticle application for mRNA vaccination
por: Yeh, Tzu-Fu, et al.
Publicado: (2023)

Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
por: Lee, Yeji, et al.
Publicado: (2023)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

mRNA lipid nanoparticle phase transition
por: Trollmann, Marius F.W., et al.
Publicado: (2022)

Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
por: Lewis, Mae M., et al.
Publicado: (2023)

Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2021)

Overcoming challenges to dissemination and implementation of research findings in under-resourced countries
por: Derman, Richard J., et al.
Publicado: (2018)

Challenges in stem cell-derived islet replacement therapy can be overcome
por: Abdulreda, Midhat H., et al.
Publicado: (2021)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

Low-dose single-shot COVID-19 mRNA vaccines lie ahead
por: Sanders, Niek N.
Publicado: (2021)

A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer
por: Kang, Ning, et al.
Publicado: (2023)

Systemic racism and overcoming my COVID-19 vaccine hesitancy
por: Nephew, Lauren D.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jrarmlg31pihsn54jc34u5eqid